nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A4—Rivastigmine—Alzheimer's disease	0.168	0.432	CbGbCtD
Salmeterol—CYP3A4—Donepezil—Alzheimer's disease	0.134	0.345	CbGbCtD
Salmeterol—CYP3A4—Galantamine—Alzheimer's disease	0.0863	0.223	CbGbCtD
Salmeterol—Urinary tract infection—Galantamine—Alzheimer's disease	0.00193	0.00337	CcSEcCtD
Salmeterol—Injury—Rivastigmine—Alzheimer's disease	0.00193	0.00337	CcSEcCtD
Salmeterol—Atrial fibrillation—Memantine—Alzheimer's disease	0.00192	0.00334	CcSEcCtD
Salmeterol—Irritability—Donepezil—Alzheimer's disease	0.00191	0.00333	CcSEcCtD
Salmeterol—Epistaxis—Galantamine—Alzheimer's disease	0.00187	0.00327	CcSEcCtD
Salmeterol—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00187	0.00327	CcSEcCtD
Salmeterol—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00183	0.00319	CcSEcCtD
Salmeterol—Pain in extremity—Memantine—Alzheimer's disease	0.00182	0.00317	CcSEcCtD
Salmeterol—Cramp muscle—Donepezil—Alzheimer's disease	0.0018	0.00314	CcSEcCtD
Salmeterol—Rhinitis—Galantamine—Alzheimer's disease	0.00179	0.00312	CcSEcCtD
Salmeterol—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00179	0.00312	CcSEcCtD
Salmeterol—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00178	0.0031	CcSEcCtD
Salmeterol—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00175	0.00306	CcSEcCtD
Salmeterol—Migraine—Rivastigmine—Alzheimer's disease	0.00175	0.00305	CcSEcCtD
Salmeterol—Irritability—Memantine—Alzheimer's disease	0.00173	0.00302	CcSEcCtD
Salmeterol—Influenza—Donepezil—Alzheimer's disease	0.00173	0.00301	CcSEcCtD
Salmeterol—Asthma—Donepezil—Alzheimer's disease	0.00173	0.00301	CcSEcCtD
Salmeterol—Bronchitis—Donepezil—Alzheimer's disease	0.00166	0.0029	CcSEcCtD
Salmeterol—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00166	0.00289	CcSEcCtD
Salmeterol—Cardiac disorder—Galantamine—Alzheimer's disease	0.00166	0.00289	CcSEcCtD
Salmeterol—Nasopharyngitis—Memantine—Alzheimer's disease	0.00162	0.00283	CcSEcCtD
Salmeterol—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00162	0.00283	CcSEcCtD
Salmeterol—Immune system disorder—Galantamine—Alzheimer's disease	0.00161	0.00281	CcSEcCtD
Salmeterol—Cramp muscle—Rivastigmine—Alzheimer's disease	0.0016	0.00279	CcSEcCtD
Salmeterol—Arrhythmia—Galantamine—Alzheimer's disease	0.00159	0.00278	CcSEcCtD
Salmeterol—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00159	0.00277	CcSEcCtD
Salmeterol—Asthma—Memantine—Alzheimer's disease	0.00157	0.00274	CcSEcCtD
Salmeterol—Influenza—Memantine—Alzheimer's disease	0.00157	0.00274	CcSEcCtD
Salmeterol—Mental disorder—Galantamine—Alzheimer's disease	0.00156	0.00273	CcSEcCtD
Salmeterol—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00156	0.00272	CcSEcCtD
Salmeterol—Malnutrition—Galantamine—Alzheimer's disease	0.00155	0.00271	CcSEcCtD
Salmeterol—Pneumonia—Donepezil—Alzheimer's disease	0.00155	0.0027	CcSEcCtD
Salmeterol—Bronchospasm—Memantine—Alzheimer's disease	0.00154	0.00269	CcSEcCtD
Salmeterol—Infestation NOS—Donepezil—Alzheimer's disease	0.00154	0.00269	CcSEcCtD
Salmeterol—Infestation—Donepezil—Alzheimer's disease	0.00154	0.00269	CcSEcCtD
Salmeterol—Tension—Galantamine—Alzheimer's disease	0.00152	0.00266	CcSEcCtD
Salmeterol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00151	0.00263	CcSEcCtD
Salmeterol—Nervousness—Galantamine—Alzheimer's disease	0.00151	0.00263	CcSEcCtD
Salmeterol—Bronchitis—Memantine—Alzheimer's disease	0.00151	0.00263	CcSEcCtD
Salmeterol—Back pain—Galantamine—Alzheimer's disease	0.0015	0.00262	CcSEcCtD
Salmeterol—Urinary tract infection—Donepezil—Alzheimer's disease	0.0015	0.00261	CcSEcCtD
Salmeterol—Conjunctivitis—Donepezil—Alzheimer's disease	0.0015	0.00261	CcSEcCtD
Salmeterol—Muscle spasms—Galantamine—Alzheimer's disease	0.00149	0.00261	CcSEcCtD
Salmeterol—Bronchitis—Rivastigmine—Alzheimer's disease	0.00148	0.00257	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00146	0.00254	CcSEcCtD
Salmeterol—Tremor—Galantamine—Alzheimer's disease	0.00146	0.00254	CcSEcCtD
Salmeterol—Epistaxis—Donepezil—Alzheimer's disease	0.00145	0.00253	CcSEcCtD
Salmeterol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00144	0.00251	CcSEcCtD
Salmeterol—Agitation—Galantamine—Alzheimer's disease	0.00143	0.00249	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00143	0.00249	CcSEcCtD
Salmeterol—Hyperglycaemia—Memantine—Alzheimer's disease	0.00142	0.00247	CcSEcCtD
Salmeterol—Pneumonia—Memantine—Alzheimer's disease	0.00141	0.00245	CcSEcCtD
Salmeterol—Malaise—Galantamine—Alzheimer's disease	0.0014	0.00244	CcSEcCtD
Salmeterol—Infestation NOS—Memantine—Alzheimer's disease	0.0014	0.00244	CcSEcCtD
Salmeterol—Infestation—Memantine—Alzheimer's disease	0.0014	0.00244	CcSEcCtD
Salmeterol—Rhinitis—Donepezil—Alzheimer's disease	0.00139	0.00242	CcSEcCtD
Salmeterol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00138	0.00242	CcSEcCtD
Salmeterol—Pneumonia—Rivastigmine—Alzheimer's disease	0.00138	0.0024	CcSEcCtD
Salmeterol—Palpitations—Galantamine—Alzheimer's disease	0.00137	0.00239	CcSEcCtD
Salmeterol—Pharyngitis—Donepezil—Alzheimer's disease	0.00137	0.00239	CcSEcCtD
Salmeterol—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00137	0.00239	CcSEcCtD
Salmeterol—Infestation—Rivastigmine—Alzheimer's disease	0.00137	0.00239	CcSEcCtD
Salmeterol—Urinary tract infection—Memantine—Alzheimer's disease	0.00136	0.00237	CcSEcCtD
Salmeterol—Conjunctivitis—Memantine—Alzheimer's disease	0.00136	0.00237	CcSEcCtD
Salmeterol—Cough—Galantamine—Alzheimer's disease	0.00136	0.00236	CcSEcCtD
Salmeterol—Hypertension—Galantamine—Alzheimer's disease	0.00134	0.00234	CcSEcCtD
Salmeterol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00133	0.00232	CcSEcCtD
Salmeterol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00133	0.00232	CcSEcCtD
Salmeterol—Myalgia—Galantamine—Alzheimer's disease	0.00132	0.00231	CcSEcCtD
Salmeterol—Chest pain—Galantamine—Alzheimer's disease	0.00132	0.00231	CcSEcCtD
Salmeterol—Arthralgia—Galantamine—Alzheimer's disease	0.00132	0.00231	CcSEcCtD
Salmeterol—Epistaxis—Memantine—Alzheimer's disease	0.00132	0.0023	CcSEcCtD
Salmeterol—Anxiety—Galantamine—Alzheimer's disease	0.00132	0.0023	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00131	0.00229	CcSEcCtD
Salmeterol—Sinusitis—Memantine—Alzheimer's disease	0.00131	0.00229	CcSEcCtD
Salmeterol—Discomfort—Galantamine—Alzheimer's disease	0.00131	0.00228	CcSEcCtD
Salmeterol—Dry mouth—Galantamine—Alzheimer's disease	0.00129	0.00226	CcSEcCtD
Salmeterol—Epistaxis—Rivastigmine—Alzheimer's disease	0.00129	0.00225	CcSEcCtD
Salmeterol—Sinusitis—Rivastigmine—Alzheimer's disease	0.00128	0.00224	CcSEcCtD
Salmeterol—Rhinitis—Memantine—Alzheimer's disease	0.00126	0.0022	CcSEcCtD
Salmeterol—Pharyngitis—Memantine—Alzheimer's disease	0.00125	0.00217	CcSEcCtD
Salmeterol—Nervous system disorder—Galantamine—Alzheimer's disease	0.00124	0.00217	CcSEcCtD
Salmeterol—Tachycardia—Galantamine—Alzheimer's disease	0.00124	0.00216	CcSEcCtD
Salmeterol—Arrhythmia—Donepezil—Alzheimer's disease	0.00124	0.00216	CcSEcCtD
Salmeterol—Connective tissue disorder—Memantine—Alzheimer's disease	0.00123	0.00215	CcSEcCtD
Salmeterol—Rhinitis—Rivastigmine—Alzheimer's disease	0.00123	0.00215	CcSEcCtD
Salmeterol—Skin disorder—Galantamine—Alzheimer's disease	0.00123	0.00215	CcSEcCtD
Salmeterol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00122	0.00213	CcSEcCtD
Salmeterol—Mental disorder—Donepezil—Alzheimer's disease	0.00121	0.00211	CcSEcCtD
Salmeterol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00121	0.00211	CcSEcCtD
Salmeterol—Malnutrition—Donepezil—Alzheimer's disease	0.0012	0.0021	CcSEcCtD
Salmeterol—Tension—Donepezil—Alzheimer's disease	0.00118	0.00206	CcSEcCtD
Salmeterol—Nervousness—Donepezil—Alzheimer's disease	0.00117	0.00204	CcSEcCtD
Salmeterol—Cardiac disorder—Memantine—Alzheimer's disease	0.00117	0.00203	CcSEcCtD
Salmeterol—Back pain—Donepezil—Alzheimer's disease	0.00116	0.00203	CcSEcCtD
Salmeterol—Muscle spasms—Donepezil—Alzheimer's disease	0.00116	0.00202	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00116	0.00202	CcSEcCtD
Salmeterol—Insomnia—Galantamine—Alzheimer's disease	0.00115	0.002	CcSEcCtD
Salmeterol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00114	0.00199	CcSEcCtD
Salmeterol—Paraesthesia—Galantamine—Alzheimer's disease	0.00114	0.00199	CcSEcCtD
Salmeterol—Immune system disorder—Memantine—Alzheimer's disease	0.00113	0.00198	CcSEcCtD
Salmeterol—Mediastinal disorder—Memantine—Alzheimer's disease	0.00113	0.00197	CcSEcCtD
Salmeterol—Tremor—Donepezil—Alzheimer's disease	0.00113	0.00197	CcSEcCtD
Salmeterol—Arrhythmia—Memantine—Alzheimer's disease	0.00112	0.00196	CcSEcCtD
Salmeterol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00112	0.00195	CcSEcCtD
Salmeterol—Dyspepsia—Galantamine—Alzheimer's disease	0.00112	0.00195	CcSEcCtD
Salmeterol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00111	0.00193	CcSEcCtD
Salmeterol—Agitation—Donepezil—Alzheimer's disease	0.00111	0.00193	CcSEcCtD
Salmeterol—Mental disorder—Memantine—Alzheimer's disease	0.0011	0.00192	CcSEcCtD
Salmeterol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.0011	0.00191	CcSEcCtD
Salmeterol—Malnutrition—Memantine—Alzheimer's disease	0.00109	0.00191	CcSEcCtD
Salmeterol—Fatigue—Galantamine—Alzheimer's disease	0.00109	0.00191	CcSEcCtD
Salmeterol—Malaise—Donepezil—Alzheimer's disease	0.00109	0.00189	CcSEcCtD
Salmeterol—Constipation—Galantamine—Alzheimer's disease	0.00108	0.00189	CcSEcCtD
Salmeterol—Mental disorder—Rivastigmine—Alzheimer's disease	0.00108	0.00188	CcSEcCtD
Salmeterol—Tension—Memantine—Alzheimer's disease	0.00107	0.00187	CcSEcCtD
Salmeterol—Malnutrition—Rivastigmine—Alzheimer's disease	0.00107	0.00187	CcSEcCtD
Salmeterol—Nervousness—Memantine—Alzheimer's disease	0.00106	0.00185	CcSEcCtD
Salmeterol—Back pain—Memantine—Alzheimer's disease	0.00106	0.00184	CcSEcCtD
Salmeterol—Cough—Donepezil—Alzheimer's disease	0.00105	0.00183	CcSEcCtD
Salmeterol—Tension—Rivastigmine—Alzheimer's disease	0.00105	0.00183	CcSEcCtD
Salmeterol—Feeling abnormal—Galantamine—Alzheimer's disease	0.00104	0.00182	CcSEcCtD
Salmeterol—Hypertension—Donepezil—Alzheimer's disease	0.00104	0.00181	CcSEcCtD
Salmeterol—Nervousness—Rivastigmine—Alzheimer's disease	0.00104	0.00181	CcSEcCtD
Salmeterol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00104	0.00181	CcSEcCtD
Salmeterol—Back pain—Rivastigmine—Alzheimer's disease	0.00103	0.0018	CcSEcCtD
Salmeterol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00103	0.00179	CcSEcCtD
Salmeterol—Chest pain—Donepezil—Alzheimer's disease	0.00102	0.00179	CcSEcCtD
Salmeterol—Myalgia—Donepezil—Alzheimer's disease	0.00102	0.00179	CcSEcCtD
Salmeterol—Arthralgia—Donepezil—Alzheimer's disease	0.00102	0.00179	CcSEcCtD
Salmeterol—Tremor—Memantine—Alzheimer's disease	0.00102	0.00179	CcSEcCtD
Salmeterol—Anxiety—Donepezil—Alzheimer's disease	0.00102	0.00178	CcSEcCtD
Salmeterol—Ill-defined disorder—Memantine—Alzheimer's disease	0.00101	0.00177	CcSEcCtD
Salmeterol—Discomfort—Donepezil—Alzheimer's disease	0.00101	0.00177	CcSEcCtD
Salmeterol—Agitation—Memantine—Alzheimer's disease	0.001	0.00175	CcSEcCtD
Salmeterol—Dry mouth—Donepezil—Alzheimer's disease	0.001	0.00175	CcSEcCtD
Salmeterol—Body temperature increased—Galantamine—Alzheimer's disease	0.001	0.00175	CcSEcCtD
Salmeterol—Abdominal pain—Galantamine—Alzheimer's disease	0.001	0.00175	CcSEcCtD
Salmeterol—Tremor—Rivastigmine—Alzheimer's disease	0.001	0.00175	CcSEcCtD
Salmeterol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000992	0.00173	CcSEcCtD
Salmeterol—Malaise—Memantine—Alzheimer's disease	0.000986	0.00172	CcSEcCtD
Salmeterol—Agitation—Rivastigmine—Alzheimer's disease	0.000983	0.00171	CcSEcCtD
Salmeterol—Oedema—Donepezil—Alzheimer's disease	0.000983	0.00171	CcSEcCtD
Salmeterol—Infection—Donepezil—Alzheimer's disease	0.000976	0.0017	CcSEcCtD
Salmeterol—Palpitations—Memantine—Alzheimer's disease	0.000966	0.00169	CcSEcCtD
Salmeterol—Malaise—Rivastigmine—Alzheimer's disease	0.000964	0.00168	CcSEcCtD
Salmeterol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000964	0.00168	CcSEcCtD
Salmeterol—Cough—Memantine—Alzheimer's disease	0.000954	0.00166	CcSEcCtD
Salmeterol—Palpitations—Rivastigmine—Alzheimer's disease	0.000945	0.00165	CcSEcCtD
Salmeterol—Hypertension—Memantine—Alzheimer's disease	0.000944	0.00165	CcSEcCtD
Salmeterol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000934	0.00163	CcSEcCtD
Salmeterol—Cough—Rivastigmine—Alzheimer's disease	0.000933	0.00163	CcSEcCtD
Salmeterol—Chest pain—Memantine—Alzheimer's disease	0.000931	0.00162	CcSEcCtD
Salmeterol—Myalgia—Memantine—Alzheimer's disease	0.000931	0.00162	CcSEcCtD
Salmeterol—Arthralgia—Memantine—Alzheimer's disease	0.000931	0.00162	CcSEcCtD
Salmeterol—Anxiety—Memantine—Alzheimer's disease	0.000927	0.00162	CcSEcCtD
Salmeterol—Hypertension—Rivastigmine—Alzheimer's disease	0.000923	0.00161	CcSEcCtD
Salmeterol—Discomfort—Memantine—Alzheimer's disease	0.000919	0.0016	CcSEcCtD
Salmeterol—Arthralgia—Rivastigmine—Alzheimer's disease	0.00091	0.00159	CcSEcCtD
Salmeterol—Chest pain—Rivastigmine—Alzheimer's disease	0.00091	0.00159	CcSEcCtD
Salmeterol—Myalgia—Rivastigmine—Alzheimer's disease	0.00091	0.00159	CcSEcCtD
Salmeterol—Dry mouth—Memantine—Alzheimer's disease	0.00091	0.00159	CcSEcCtD
Salmeterol—Asthenia—Galantamine—Alzheimer's disease	0.00091	0.00159	CcSEcCtD
Salmeterol—Anxiety—Rivastigmine—Alzheimer's disease	0.000907	0.00158	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000904	0.00158	CcSEcCtD
Salmeterol—Discomfort—Rivastigmine—Alzheimer's disease	0.0009	0.00157	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000895	0.00156	CcSEcCtD
Salmeterol—Oedema—Memantine—Alzheimer's disease	0.000892	0.00156	CcSEcCtD
Salmeterol—Dry mouth—Rivastigmine—Alzheimer's disease	0.00089	0.00155	CcSEcCtD
Salmeterol—Insomnia—Donepezil—Alzheimer's disease	0.000889	0.00155	CcSEcCtD
Salmeterol—Infection—Memantine—Alzheimer's disease	0.000886	0.00155	CcSEcCtD
Salmeterol—Paraesthesia—Donepezil—Alzheimer's disease	0.000882	0.00154	CcSEcCtD
Salmeterol—Dyspnoea—Donepezil—Alzheimer's disease	0.000876	0.00153	CcSEcCtD
Salmeterol—Nervous system disorder—Memantine—Alzheimer's disease	0.000875	0.00153	CcSEcCtD
Salmeterol—Oedema—Rivastigmine—Alzheimer's disease	0.000873	0.00152	CcSEcCtD
Salmeterol—Tachycardia—Memantine—Alzheimer's disease	0.000871	0.00152	CcSEcCtD
Salmeterol—Diarrhoea—Galantamine—Alzheimer's disease	0.000867	0.00151	CcSEcCtD
Salmeterol—Infection—Rivastigmine—Alzheimer's disease	0.000867	0.00151	CcSEcCtD
Salmeterol—Skin disorder—Memantine—Alzheimer's disease	0.000867	0.00151	CcSEcCtD
Salmeterol—Dyspepsia—Donepezil—Alzheimer's disease	0.000865	0.00151	CcSEcCtD
Salmeterol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000856	0.00149	CcSEcCtD
Salmeterol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000852	0.00149	CcSEcCtD
Salmeterol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000848	0.00148	CcSEcCtD
Salmeterol—Fatigue—Donepezil—Alzheimer's disease	0.000847	0.00148	CcSEcCtD
Salmeterol—Pain—Donepezil—Alzheimer's disease	0.00084	0.00147	CcSEcCtD
Salmeterol—Constipation—Donepezil—Alzheimer's disease	0.00084	0.00147	CcSEcCtD
Salmeterol—Dizziness—Galantamine—Alzheimer's disease	0.000838	0.00146	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000813	0.00142	CcSEcCtD
Salmeterol—Feeling abnormal—Donepezil—Alzheimer's disease	0.00081	0.00141	CcSEcCtD
Salmeterol—Insomnia—Memantine—Alzheimer's disease	0.000807	0.00141	CcSEcCtD
Salmeterol—Vomiting—Galantamine—Alzheimer's disease	0.000806	0.00141	CcSEcCtD
Salmeterol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000803	0.0014	CcSEcCtD
Salmeterol—Paraesthesia—Memantine—Alzheimer's disease	0.000801	0.0014	CcSEcCtD
Salmeterol—Rash—Galantamine—Alzheimer's disease	0.000799	0.00139	CcSEcCtD
Salmeterol—Dermatitis—Galantamine—Alzheimer's disease	0.000799	0.00139	CcSEcCtD
Salmeterol—Dyspnoea—Memantine—Alzheimer's disease	0.000795	0.00139	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000795	0.00139	CcSEcCtD
Salmeterol—Headache—Galantamine—Alzheimer's disease	0.000794	0.00139	CcSEcCtD
Salmeterol—Insomnia—Rivastigmine—Alzheimer's disease	0.000789	0.00138	CcSEcCtD
Salmeterol—Dyspepsia—Memantine—Alzheimer's disease	0.000785	0.00137	CcSEcCtD
Salmeterol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000784	0.00137	CcSEcCtD
Salmeterol—Urticaria—Donepezil—Alzheimer's disease	0.000781	0.00136	CcSEcCtD
Salmeterol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000778	0.00136	CcSEcCtD
Salmeterol—Abdominal pain—Donepezil—Alzheimer's disease	0.000777	0.00136	CcSEcCtD
Salmeterol—Body temperature increased—Donepezil—Alzheimer's disease	0.000777	0.00136	CcSEcCtD
Salmeterol—Fatigue—Memantine—Alzheimer's disease	0.000769	0.00134	CcSEcCtD
Salmeterol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000768	0.00134	CcSEcCtD
Salmeterol—Pain—Memantine—Alzheimer's disease	0.000763	0.00133	CcSEcCtD
Salmeterol—Constipation—Memantine—Alzheimer's disease	0.000763	0.00133	CcSEcCtD
Salmeterol—Nausea—Galantamine—Alzheimer's disease	0.000753	0.00131	CcSEcCtD
Salmeterol—Fatigue—Rivastigmine—Alzheimer's disease	0.000752	0.00131	CcSEcCtD
Salmeterol—Constipation—Rivastigmine—Alzheimer's disease	0.000746	0.0013	CcSEcCtD
Salmeterol—Pain—Rivastigmine—Alzheimer's disease	0.000746	0.0013	CcSEcCtD
Salmeterol—Feeling abnormal—Memantine—Alzheimer's disease	0.000735	0.00128	CcSEcCtD
Salmeterol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00073	0.00127	CcSEcCtD
Salmeterol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000724	0.00126	CcSEcCtD
Salmeterol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000719	0.00125	CcSEcCtD
Salmeterol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000714	0.00125	CcSEcCtD
Salmeterol—Urticaria—Memantine—Alzheimer's disease	0.000709	0.00124	CcSEcCtD
Salmeterol—Abdominal pain—Memantine—Alzheimer's disease	0.000705	0.00123	CcSEcCtD
Salmeterol—Body temperature increased—Memantine—Alzheimer's disease	0.000705	0.00123	CcSEcCtD
Salmeterol—Asthenia—Donepezil—Alzheimer's disease	0.000705	0.00123	CcSEcCtD
Salmeterol—Urticaria—Rivastigmine—Alzheimer's disease	0.000693	0.00121	CcSEcCtD
Salmeterol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00069	0.0012	CcSEcCtD
Salmeterol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00069	0.0012	CcSEcCtD
Salmeterol—Diarrhoea—Donepezil—Alzheimer's disease	0.000672	0.00117	CcSEcCtD
Salmeterol—Hypersensitivity—Memantine—Alzheimer's disease	0.000657	0.00115	CcSEcCtD
Salmeterol—Dizziness—Donepezil—Alzheimer's disease	0.00065	0.00113	CcSEcCtD
Salmeterol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000643	0.00112	CcSEcCtD
Salmeterol—Asthenia—Memantine—Alzheimer's disease	0.00064	0.00112	CcSEcCtD
Salmeterol—Asthenia—Rivastigmine—Alzheimer's disease	0.000626	0.00109	CcSEcCtD
Salmeterol—Vomiting—Donepezil—Alzheimer's disease	0.000625	0.00109	CcSEcCtD
Salmeterol—Rash—Donepezil—Alzheimer's disease	0.00062	0.00108	CcSEcCtD
Salmeterol—Dermatitis—Donepezil—Alzheimer's disease	0.000619	0.00108	CcSEcCtD
Salmeterol—Headache—Donepezil—Alzheimer's disease	0.000616	0.00107	CcSEcCtD
Salmeterol—Diarrhoea—Memantine—Alzheimer's disease	0.00061	0.00106	CcSEcCtD
Salmeterol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000597	0.00104	CcSEcCtD
Salmeterol—Dizziness—Memantine—Alzheimer's disease	0.00059	0.00103	CcSEcCtD
Salmeterol—Nausea—Donepezil—Alzheimer's disease	0.000584	0.00102	CcSEcCtD
Salmeterol—Dizziness—Rivastigmine—Alzheimer's disease	0.000577	0.00101	CcSEcCtD
Salmeterol—Vomiting—Memantine—Alzheimer's disease	0.000567	0.00099	CcSEcCtD
Salmeterol—Rash—Memantine—Alzheimer's disease	0.000563	0.000981	CcSEcCtD
Salmeterol—Dermatitis—Memantine—Alzheimer's disease	0.000562	0.00098	CcSEcCtD
Salmeterol—Headache—Memantine—Alzheimer's disease	0.000559	0.000975	CcSEcCtD
Salmeterol—Vomiting—Rivastigmine—Alzheimer's disease	0.000555	0.000968	CcSEcCtD
Salmeterol—Rash—Rivastigmine—Alzheimer's disease	0.00055	0.00096	CcSEcCtD
Salmeterol—Dermatitis—Rivastigmine—Alzheimer's disease	0.00055	0.000959	CcSEcCtD
Salmeterol—Headache—Rivastigmine—Alzheimer's disease	0.000547	0.000954	CcSEcCtD
Salmeterol—Nausea—Memantine—Alzheimer's disease	0.00053	0.000924	CcSEcCtD
Salmeterol—Nausea—Rivastigmine—Alzheimer's disease	0.000518	0.000904	CcSEcCtD
Salmeterol—Labetalol—CYP2D6—Alzheimer's disease	0.000338	0.567	CrCbGaD
Salmeterol—Propafenone—CYP2D6—Alzheimer's disease	0.000258	0.433	CrCbGaD
Salmeterol—ADRB2—GPCR ligand binding—SST—Alzheimer's disease	6.98e-05	0.00182	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR6—Alzheimer's disease	6.93e-05	0.0018	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	6.89e-05	0.0018	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GAPDHS—Alzheimer's disease	6.85e-05	0.00178	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—APP—Alzheimer's disease	6.8e-05	0.00177	CbGpPWpGaD
Salmeterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	6.75e-05	0.00176	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.7e-05	0.00175	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CDK5—Alzheimer's disease	6.54e-05	0.0017	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ATP5A1—Alzheimer's disease	6.49e-05	0.00169	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR6—Alzheimer's disease	6.29e-05	0.00164	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLD3—Alzheimer's disease	6.19e-05	0.00161	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	6.19e-05	0.00161	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HSD17B10—Alzheimer's disease	5.94e-05	0.00155	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	5.91e-05	0.00154	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	5.78e-05	0.00151	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	5.75e-05	0.0015	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP46A1—Alzheimer's disease	5.71e-05	0.00149	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ND1—Alzheimer's disease	5.52e-05	0.00144	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	5.36e-05	0.0014	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CA4—Alzheimer's disease	5.26e-05	0.00137	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	5.23e-05	0.00136	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	5.09e-05	0.00133	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	5.08e-05	0.00132	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	5.07e-05	0.00132	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5e-05	0.0013	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.98e-05	0.0013	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	4.95e-05	0.00129	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.91e-05	0.00128	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	4.69e-05	0.00122	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CA4—Alzheimer's disease	4.56e-05	0.00119	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	4.52e-05	0.00118	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	4.52e-05	0.00118	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	4.5e-05	0.00117	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	4.49e-05	0.00117	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLD3—Alzheimer's disease	4.48e-05	0.00117	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.46e-05	0.00116	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	4.45e-05	0.00116	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	4.4e-05	0.00115	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	4.36e-05	0.00114	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	4.29e-05	0.00112	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	4.29e-05	0.00112	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	4.13e-05	0.00108	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	4.13e-05	0.00108	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	4.1e-05	0.00107	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	4.08e-05	0.00106	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	4.06e-05	0.00106	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ND1—Alzheimer's disease	3.99e-05	0.00104	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	3.96e-05	0.00103	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	3.94e-05	0.00103	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	3.94e-05	0.00103	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLD3—Alzheimer's disease	3.88e-05	0.00101	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.88e-05	0.00101	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	3.86e-05	0.00101	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	3.86e-05	0.001	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	3.84e-05	0.001	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.83e-05	0.000998	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	3.75e-05	0.000978	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.74e-05	0.000973	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	3.72e-05	0.000968	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	3.72e-05	0.000968	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.63e-05	0.000946	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.63e-05	0.000945	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	3.58e-05	0.000933	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	3.58e-05	0.000933	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	3.58e-05	0.000932	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CHAT—Alzheimer's disease	3.56e-05	0.000926	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—TPI1—Alzheimer's disease	3.56e-05	0.000926	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	3.49e-05	0.000909	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ND1—Alzheimer's disease	3.46e-05	0.0009	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	3.44e-05	0.000896	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MAOB—Alzheimer's disease	3.41e-05	0.000888	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.38e-05	0.00088	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	3.38e-05	0.000879	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	3.33e-05	0.000867	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	3.29e-05	0.000858	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	3.28e-05	0.000855	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	3.24e-05	0.000844	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—A2M—Alzheimer's disease	3.17e-05	0.000826	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	3.16e-05	0.000823	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.09e-05	0.000805	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	3.09e-05	0.000804	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	3.09e-05	0.000804	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.88e-05	0.00075	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ACHE—Alzheimer's disease	2.76e-05	0.000718	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	2.73e-05	0.00071	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	2.72e-05	0.000709	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.68e-05	0.000699	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.66e-05	0.000693	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	2.63e-05	0.000686	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ENO1—Alzheimer's disease	2.58e-05	0.000673	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	2.58e-05	0.000673	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CHAT—Alzheimer's disease	2.57e-05	0.00067	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—TPI1—Alzheimer's disease	2.57e-05	0.00067	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	2.54e-05	0.000662	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	2.53e-05	0.00066	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.49e-05	0.000648	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MAOB—Alzheimer's disease	2.46e-05	0.000642	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.45e-05	0.000637	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.44e-05	0.000634	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	2.42e-05	0.000632	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.42e-05	0.000631	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	2.41e-05	0.000628	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—BCHE—Alzheimer's disease	2.4e-05	0.000626	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.37e-05	0.000618	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	2.34e-05	0.000609	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	2.31e-05	0.000601	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.3e-05	0.000599	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.29e-05	0.000597	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	2.27e-05	0.00059	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	2.26e-05	0.000588	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—TPI1—Alzheimer's disease	2.23e-05	0.00058	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CHAT—Alzheimer's disease	2.23e-05	0.00058	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	2.22e-05	0.000578	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	2.21e-05	0.000575	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	2.2e-05	0.000572	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.18e-05	0.000568	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	2.18e-05	0.000568	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	2.17e-05	0.000566	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MAOB—Alzheimer's disease	2.13e-05	0.000556	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	2.12e-05	0.000551	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	2.12e-05	0.000551	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	2.12e-05	0.000551	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	2.11e-05	0.000549	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	2.1e-05	0.000546	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.08e-05	0.000542	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	2.06e-05	0.000537	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	2.05e-05	0.000535	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.03e-05	0.000529	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.01e-05	0.000524	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2e-05	0.00052	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.99e-05	0.000519	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.98e-05	0.000517	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.98e-05	0.000516	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.97e-05	0.000513	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.95e-05	0.000507	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.92e-05	0.0005	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	1.89e-05	0.000493	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	1.89e-05	0.000491	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.87e-05	0.000487	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.87e-05	0.000487	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.85e-05	0.000483	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.83e-05	0.000477	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.82e-05	0.000473	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.8e-05	0.00047	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.77e-05	0.000462	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.77e-05	0.000461	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.76e-05	0.00046	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.74e-05	0.000452	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.73e-05	0.00045	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPL—Alzheimer's disease	1.72e-05	0.000449	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.71e-05	0.000445	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1.68e-05	0.000437	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.64e-05	0.000427	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.62e-05	0.000421	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.62e-05	0.000421	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.6e-05	0.000416	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.59e-05	0.000414	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.59e-05	0.000413	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.55e-05	0.000404	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.54e-05	0.000402	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.5e-05	0.000392	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.48e-05	0.000385	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.47e-05	0.000382	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.45e-05	0.000378	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.45e-05	0.000376	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	1.44e-05	0.000375	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.43e-05	0.000373	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.42e-05	0.00037	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	1.4e-05	0.000365	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.39e-05	0.000363	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.38e-05	0.000358	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.37e-05	0.000357	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	1.36e-05	0.000355	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.36e-05	0.000355	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	1.33e-05	0.000347	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.26e-05	0.000328	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.25e-05	0.000325	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	1.24e-05	0.000324	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	1.24e-05	0.000323	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	1.24e-05	0.000323	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—INS—Alzheimer's disease	1.23e-05	0.000322	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	1.23e-05	0.00032	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.2e-05	0.000311	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.2e-05	0.000311	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.19e-05	0.000309	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	1.18e-05	0.000308	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.18e-05	0.000307	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	1.17e-05	0.000305	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.15e-05	0.000298	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.14e-05	0.000298	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.12e-05	0.000292	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	0.000287	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.08e-05	0.000282	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.08e-05	0.000281	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	1.07e-05	0.00028	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	1.07e-05	0.000278	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.07e-05	0.000277	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	1.06e-05	0.000276	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.05e-05	0.000273	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.04e-05	0.000272	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	1.04e-05	0.000272	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.04e-05	0.00027	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	1.02e-05	0.000267	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	9.9e-06	0.000258	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	9.72e-06	0.000253	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	9.29e-06	0.000242	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.27e-06	0.000241	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.16e-06	0.000239	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARG—Alzheimer's disease	9.1e-06	0.000237	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CALM1—Alzheimer's disease	9.08e-06	0.000237	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—Alzheimer's disease	9.05e-06	0.000236	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAV1—Alzheimer's disease	8.96e-06	0.000234	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—INS—Alzheimer's disease	8.92e-06	0.000232	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.68e-06	0.000226	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.68e-06	0.000226	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.52e-06	0.000222	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.07e-06	0.00021	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	7.96e-06	0.000207	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	7.89e-06	0.000205	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARG—Alzheimer's disease	7.88e-06	0.000205	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	7.84e-06	0.000204	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—Alzheimer's disease	7.83e-06	0.000204	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—INS—Alzheimer's disease	7.73e-06	0.000201	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.62e-06	0.000198	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.38e-06	0.000192	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	7.25e-06	0.000189	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	7.23e-06	0.000188	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	7.16e-06	0.000186	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—Alzheimer's disease	6.78e-06	0.000177	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	6.69e-06	0.000174	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.36e-06	0.000166	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.33e-06	0.000165	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	6.2e-06	0.000161	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	6.14e-06	0.00016	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.79e-06	0.000151	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.22e-06	0.000136	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	5.06e-06	0.000132	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AKT1—Alzheimer's disease	4.98e-06	0.00013	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.87e-06	0.000127	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.86e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.81e-06	0.000125	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	4.63e-06	0.000121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	4.27e-06	0.000111	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.23e-06	0.00011	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INS—Alzheimer's disease	4.15e-06	0.000108	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.64e-06	9.48e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.6e-06	9.37e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.33e-06	8.67e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKT1—Alzheimer's disease	3.12e-06	8.12e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.67e-06	4.36e-05	CbGpPWpGaD
